BRZE stock forecast, quote, news & analysis
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands... Show more
Why Braze (BRZE) Stock Is Up +20.4% in the Last 30 Days
Key Takeaways
- Braze (BRZE) shares advanced about 20.4% over the trailing 30 days, climbing from a closing price of $26.54 on Aug. 7, 2026, to $31.96 at the Sept. 4, 2026 close.
- Momentum accelerated in mid-to-late August following a wave of analyst price-target increases from BTIG, TD Cowen, and Oppenheimer, plus a Barclays Buy reiteration.
- Investor enthusiasm is concentrated on Braze's AI product suite — including Decisioning Studio, BrazeAI Operator, and BrazeAI Agent Console — and its enterprise expansion.
- Over the trailing quarter, the stock has rebounded roughly 39.5%, recovering from a mid-June trough near $19.21.
- Attention now shifts to fiscal Q2 FY2027 results, with consensus estimates near $220 million in revenue and $0.15 in non-GAAP earnings per share.
Braze (BRZE) Company Overview and Market Position
Braze, Inc. is a customer engagement platform that helps consumer-facing brands orchestrate real-time, personalized marketing across channels including email, push notifications, in-app messaging, and SMS. Its software consolidates customer data, enables journey orchestration, and powers AI-driven decisioning for marketers. Braze positions itself as a modern alternative to legacy marketing clouds and point solutions, competing for enterprise budgets against larger suites from Salesforce (CRM) and Adobe (ADBE). Investors track the stock for its revenue growth, dollar-based net retention, remaining performance obligations, and progress toward sustained profitability, as well as the monetization of its newer AI offerings.
Braze (BRZE) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, BRZE rose from a closing price of $26.54 on Aug. 7, 2026, to $31.96 on Sept. 4, 2026 — a gain of roughly $5.42, or +20.4%. The move was not a straight line: the stock climbed steadily through the middle of August, reached an intraday high around $35.02 on Aug. 28, and then pulled back modestly into early September as some traders locked in gains ahead of earnings.
The quarterly picture reflects a broader recovery. Three months earlier, shares closed near $22.91, and the stock bottomed around $19.21 in late June. Since then, BRZE has advanced roughly 39.5%, reflecting a sustained rotation back into high-growth software after a difficult start to the year.
What Drove BRZE Stock Price in the Last 30 Days
The 30-day advance was driven primarily by a cluster of bullish analyst actions and growing confidence in Braze's AI roadmap. On Aug. 14, BTIG raised its price target to $35 while reiterating a Buy rating, citing stronger bookings momentum and improving enterprise demand. Later in August, both Oppenheimer and TD Cowen lifted their targets to $36, with Oppenheimer highlighting resilient demand for Braze's AI decisioning and orchestration products. Barclays also reiterated its Buy stance. Oppenheimer's note coincided with a roughly 9% single-session jump in the stock.
Underpinning the sentiment shift is Braze's AI portfolio, led by Decisioning Studio, BrazeAI Operator, and BrazeAI Agent Console, which management has described as contributors to accelerating growth. The company also announced the appointment of a new Chief Product Officer, reinforcing its product-focused narrative. Peer commentary from marketing-technology names such as Twilio (TWLO) and Klaviyo (KVYO) was additionally read as a positive signal for the customer engagement category.
What Drove BRZE Stock Performance Over the Last Quarter
Over the trailing three months, BRZE staged a significant recovery from a depressed base. After declining sharply in the first half of the year — shares touched a 52-week low near $15.26 — sentiment began to turn following fiscal Q1 FY2027 results reported in late May, when revenue rose 30.2% year over year to $211 million and the company raised its full-year revenue outlook. Goldman Sachs initiated coverage with a Buy rating and a $34 target in late June, arguing Braze is well positioned to take share from legacy marketing tools as AI increases pressure on outdated technology stacks. That reset in expectations, combined with easing macro pressure on software valuations and steady analyst upgrades through August, fueled the stock's roughly 39.5% quarterly rebound.
Trending AI Robots
Tickeron's Trending AI Robots page showcases a curated selection of AI-driven trading bots. While Tickeron's platform features hundreds of bots actively trading thousands of tickers, only the top-performing and most relevant strategies appear in this section at any given time. These bots vary in approach, holding period, and performance metrics, giving traders a way to observe how algorithmic strategies are positioning across the market. Investors following names like Braze can use the page to monitor whether AI systems are turning more constructive or defensive on a given stock. Explore the page to see which strategies are currently leading.
BRZE Stock Forecast Drivers: What Investors Should Watch Next
Braze's fiscal Q2 FY2027 earnings report is the near-term focal point. Consensus estimates point to roughly $220 million in revenue and $0.15 in non-GAAP earnings per share, and investors will watch current remaining performance obligations, dollar-based net retention, and guidance for the second half of the fiscal year. Commentary on AI product adoption — particularly Decisioning Studio — and on gross margin stability will also matter, since services and messaging costs tied to AI products have been a recurring margin consideration. Beyond the report, monitor the pace of enterprise bookings, competitive dynamics against larger marketing suites from Salesforce (CRM) and Adobe (ADBE), and the broader interest-rate environment, which influences valuations for high-growth software.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BRZE sees MACD Histogram just turned negative
BRZE saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 04, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 34 instances where the indicator turned negative. In 29 of the 34 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 85%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BRZE as a result. In 64 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
BRZE moved below its 50-day moving average on September 09, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRZE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 50-day moving average for BRZE moved above the 200-day moving average on August 21, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +1.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRZE advanced for three days, in 237 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
BRZE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 153 of 190 cases where BRZE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. BRZE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.591) is normal, around the industry mean (28.382). P/E Ratio (0.000) is within average values for comparable stocks, (75.459). Projected Growth (PEG Ratio) (1.264) is also within normal values, averaging (1.599). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (3.213) is also within normal values, averaging (77.824).
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRZE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PackagedSoftware